Grants Totaling $500,000 for Researchers of AIDS Drugs

Researchers working anywhere in the world toward breakthroughs in HIV/AIDS drug therapies have until July 31, 2003, to apply.

The one-time research grants range from US$25,000 to $150,000 and are intended to further the development of inventive treatments for HIV/AIDS, including therapies aimed at treating infection, prophylactic vaccines, or microbicides designed to prevent transmission of the virus. Since inception of the program, GSK has honored nine researchers for their groundbreaking work toward new pharmaceutical strategies to combat HIV.

Research grant recipients will be announced in September 2003 at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago (IL, USA). The grants will be paid on November 1, 2003. Detailed information as well as an application are available on the grant website (www.dddresearchgrant.com).

GSK >>



Related Links:
GlaxoSmithKline
Grant Info website